The rising popularity in GLP-1 agonists for diabetes has led to a debate about application forms : skin-applied devices versus capsules. Traditionally , GLP-1 therapies were solely available in oral form, https://blakezneo386719.wssblogs.com/40852316/glp-1-transdermal-delivery-systems-vs-pills-what-right-for-the-patient